DR REDDYS LABORATORIES
Back to Balance Sheet
|
DR REDDYS LABORATORIES Last 5 Year Contingent Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Contingent Liabilities | ₹109 Cr | ₹109 Cr | ₹107 Cr | ₹108 Cr | ₹96 Cr |
What is the latest Contingent Liabilities ratio of DR REDDYS LABORATORIES ?
| Year | Contingent Liabilities |
|---|---|
| Mar2025 | ₹109 Cr |
| Mar2024 | ₹109 Cr |
| Mar2023 | ₹107 Cr |
| Mar2022 | ₹108 Cr |
| Mar2021 | ₹96 Cr |
How is Contingent Liabilities of DR REDDYS LABORATORIES Trending?
| Years | Contingent Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹109 Cr | 0.00 | |
| Mar2024 | ₹109 Cr | 1.77 | |
| Mar2023 | ₹107 Cr | -0.37 | |
| Mar2022 | ₹108 Cr | 11.62 | |
| Mar2021 | ₹96 Cr | - | |
Compare Contingent Liabilities of peers of DR REDDYS LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| DR REDDYS LABORATORIES | ₹108,823.5 Cr | 1.3% | 5.1% | 17.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹431,628.0 Cr | 3.5% | 5.6% | 11.9% | Stock Analytics | |
| DIVIS LABORATORIES | ₹167,975.0 Cr | -1.3% | 4.5% | 16.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹145,804.0 Cr | -0.7% | 6.9% | 47.8% | Stock Analytics | |
| CIPLA | ₹106,768.0 Cr | -1.9% | -0.3% | -6% | Stock Analytics | |
| MANKIND PHARMA | ₹90,257.8 Cr | -2.7% | 4.6% | -2.8% | Stock Analytics | |
DR REDDYS LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| DR REDDYS LABORATORIES | 1.3% |
5.1% |
17.5% |
| SENSEX | -4.1% |
-5.8% |
5.8% |
You may also like the below Video Courses